Quest Diagnostics Q2 financial results: 5 things to know

Quest Diagnostics released its financial results for the second quarter of 2022. Five things to know:

Advertisement

1. Quest posted second quarter revenues of $2.45 billion, down 3.8 percent from 2021.

2. Diluted earnings per share fell to $1.96, down 60.5 percent from 2021.

3. Base business revenues increased 2.9 percent from 2021 to $2.1 billion.

4. Diluted earnings per share for the full year are now expected to land between $8.24 ad $8.64.

5. Quest earned $355 million from COVID-19 testing in the second quarter, down 30.5 percent from the same period in 2021.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.